Ikena Oncology, and Inmagene Biopharmaceuticals announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio, of the combined company after the...
Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...
Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...
